Meet an Unreasonable Venture
Hilab
Democratizing access to healthcare through localised lab testing
Headquartered in Brazil, Hilab offers a remote diagnostic tool to make healthcare accessible everywhere. Their handheld devices, powered by AI and IoT, conduct quick tests that account for 85% of the most commonly administered tests. They bring the resources of the lab to distant, untouched places where others don't venture.
To date, Hilab has given over 6 million tests to 1.8 million Brazilians. Now, they're setting their sights abroad. In 2021, they introduced the world's smallest CBC tester, the Hilab Lens. The Lens uses fingerstick blood collection to provide diagnostic results from anywhere in just 30 minutes. In 2022, the Lens company received the "Gold" award from the iF DESIGN Awards—widely considered to be the world's most influential design award.
Notable Achievements
- Disruptive Point-of-Care Testing with AI: Hilab has successfully disrupted traditional diagnostic testing by integrating AI into their point-of-care testing solutions.
- Enhanced Healthcare Access: Hilab's user-friendly platform and decentralized approach have significantly improved healthcare access, especially in underserved areas. (>5,000 deployed minilabs, >2M served patients, >6M exams, >50% of Brazilian population lives less than 4 miles of a Hilab).
- Hilab Lens - Revolutionary Diagnostics: Hilab's groundbreaking launch of the Hilab Lens, the world's only technology capable of performing a complete blood count via microscopy, has redefined diagnostic standards.
Currently Operating in One Region
More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Hilab and over 386 other ventures working to solve the world's toughest problems.